BeOne Medicines Ltd.SSE: 688235

Announcement on Convening the Q3 2024 Performance Briefing

Nov 6, 2024 · Issued by BeOne Medicines Ltd. via Shanghai Stock Exchange

Filed with SSE · Nov 6, 2024

On 6ix: 6ix.com/news/announcement-on-convening-the-q3-2024-performance-briefing-429

Announcement on Convening the Q3 2024 Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

BeOne Medicines Ltd. on 6ix

Earlier from BeOne Medicines

Announcement on the Death of the Independent Non-executive DirectorOct 29, 2024
Announcement on the Appointment of Independent Non-executive Directors and Members of Audit Committee of the Board of DirectorsSep 27, 2024
Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2024Sep 21, 2024
Semi-annual Report in 2024Aug 30, 2024
Announcement on Convening Semi-annual Performance Briefing 2024Aug 22, 2024

Later from BeOne Medicines

Announcement on Using Partial Extra Raised Funds to Supplement Current Capital PermanentlyNov 13, 2024
Announcement on Proposed Change of Company's English NameNov 15, 2024
Announcement on Voluntary Disclosure of the Incorporation of Commercial Products for Multiple Indications into the New Catalogue of Drugs for Basic National Medical InsuranceNov 29, 2024
Announcement on Voluntary Disclosure of the Change of the Company's NASDAQ Stock CodeDec 24, 2024
Announcement on the Equity Registration Date for the 1st Extraordinary General Meeting (Shareholders' Special Meeting) in 2025Jan 18, 2025

All BeOne Medicines news releases

Follow BeOne Medicines into a list and get an email when it puts out news.

Follow BeOne Medicines